TEM7 Antibodies

Santa Cruz Biotechnology provides a broad selection of TEM7 Antibodies for understanding the role of Tumor Endothelial Marker 7 (TEM7) protein. TEM7 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TEM7 is a cell surface protein that plays a critical role in tumor angiogenesis and the development of the vascular system in tumors. Expression patterns of TEM7 are often associated with various cancer types, making it a significant target for cancer research and therapeutic interventions. Understanding TEM7 function can provide insights into tumor progression and potential treatment strategies. Researchers studying TEM7 can utilize specific monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced detection capabilities. Advanced research techniques incorporating TEM7 monoclonal antibodies enable detailed analysis of tumor microenvironments and vascular development. Ongoing studies of TEM7 continue to reveal new aspects of cancer biology and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for TEM7 support researchers worldwide in advancing cancer research and developing innovative treatment approaches.